The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Nanoparticle approaches against bacterial infections
Open accessAbstract
Despite the wide success of antibiotics, the treatment of bacterial infections still faces significant challenges, particularly the emergence of antibiotic resistance. As a result, nanoparticle drug delivery platforms including liposomes, polymeric nanoparticles, dendrimers, and various inorganic nanoparticles have been increasingly exploited to enhance the therapeutic effectiveness of existing antibiotics. This review focuses on areas where nanoparticle approaches hold significant potential to advance the treatment of bacterial infections. These areas include targeted antibiotic delivery, environmentally responsive antibiotic delivery, combinatorial antibiotic delivery, nanoparticle‐enabled antibacterial vaccination, and nanoparticle‐based bacterial detection. In each area we highlight the innovative antimicrobial nanoparticle platforms and review their progress made against bacterial infections.WIREs Nanomed Nanobiotechnol 2014, 6:532–547. doi: 10.1002/wnan.1282 This article is categorized under:Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
The use of nanocrystals in biological detection
Alivisatos, P. (2004) · Nature Biotechnology · doi:10.1038/nbt927 · Cited by 3,008
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., & Pittet, D. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61458-4 · Cited by 2,514
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
Katz, E., & Willner, I. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200400651 · Cited by 2,450
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Self-citationThe challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Microfluidic diagnostic technologies for global public health
Yager, P., Edwards, T., Fu, E., Helton, K., Nelson, K., Tam, M. R., & Weigl, B. H. (2006) · Nature · doi:10.1038/nature05064 · Cited by 1,979
Multifunctional Magnetic Nanoparticles: Design, Synthesis, and Biomedical Applications
Gao, J., Gu, H., & Xu, B. (2009) · Accounts of Chemical Research · doi:10.1021/ar9000026 · Cited by 1,907
The Chemistry and Applications of Antimicrobial Polymers: A State-of-the-Art Review
Kenawy, E.-R., Worley, S. D., & Broughton, R. (2007) · Biomacromolecules · doi:10.1021/bm061150q · Cited by 1,558
Kararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Performance comparison of benchtop high-throughput sequencing platforms
Loman, N. J., Misra, R. V., Dallman, T. J., Constantinidou, C., Gharbia, S. E., Wain, J., & Pallen, M. J. (2012) · Nature Biotechnology · doi:10.1038/nbt.2198 · Cited by 1,337
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Self-citationRegulation of Phagosome Maturation by Signals from Toll-Like Receptors
Blander, J. M., & Medzhitov, R. (2004) · Science · doi:10.1126/science.1096158 · Cited by 991
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Self-citationThe pH of the Skin Surface and Its Impact on the Barrier Function
Schmid-Wendtner, M.-H., & Korting, H. C. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000094670 · Cited by 860
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Point-of-care nucleic acid testing for infectious diseases
Niemz, A., Ferguson, T. M., & Boyle, D. S. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.01.007 · Cited by 838
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751
Self-citationMicrofluidic Digital PCR Enables Multigene Analysis of Individual Environmental Bacteria
Ottesen, E. A., Hong, J. W., Quake, S. R., & Leadbetter, J. R. (2006) · Science · doi:10.1126/science.1131370 · Cited by 737
Gupta, A. K., Naregalkar, R. R., Vaidya, V. D., & Gupta, M. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.23 · Cited by 708
Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities
Gu, H., Ho, P. L., Tong, E., Wang, L., & Xu, B. (2003) · Nano Letters · doi:10.1021/nl034396z · Cited by 703
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Microfluidic Applications of Magnetic Particles for Biological Analysis and Catalysis
Gijs, M. A. M., Lacharme, F., & Lehmann, U. (2010) · Chemical Reviews · doi:10.1021/cr9001929 · Cited by 679
Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent
Liu, L., Xu, K., Wang, H., Jeremy Tan, P. K., Fan, W., Venkatraman, S. S., Li, L., & Yang, Y.-Y. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.153 · Cited by 670
The Future of Antibiotics and Resistance
Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1215093 · Cited by 647
The fluoroquinolone antibacterials: past, present and future perspectives
Appelbaum, P. C., & Hunter, P. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 629
Biodegradable nanostructures with selective lysis of microbial membranes
Nederberg, F., Zhang, Y., Tan, J. P. K., Xu, K., Wang, H., Yang, C., Gao, S., Guo, X. D., Fukushima, K., Li, L., et al. (2011) · Nature Chemistry · doi:10.1038/nchem.1012 · Cited by 614
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles
Zhao, X., Hilliard, L. R., Mechery, S. J., Wang, Y., Bagwe, R. P., Jin, S., & Tan, W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404806101 · Cited by 569
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Self-citationNanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Tailoring nanocarriers for intracellular protein delivery
Gu, Z., Biswas, A., Zhao, M., & Tang, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00227e · Cited by 543
Radovic-Moreno, A. F., Lu, T. K., Puscasu, V. A., Yoon, C. J., Langer, R., & Farokhzad, O. C. (2012) · ACS Nano · doi:10.1021/nn3008383 · Cited by 539
The Perpetual Challenge of Infectious Diseases
Fauci, A. S., & Morens, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108296 · Cited by 517
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Nochi, T., Yuki, Y., Takahashi, H., Sawada, S.-I., Mejima, M., Kohda, T., Harada, N., Kong, I. G., Sato, A., Kataoka, N., et al. (2010) · Nature Materials · doi:10.1038/nmat2784 · Cited by 468
Nanotechnology in clinical laboratory diagnostics
Jain, K. K. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.014 · Cited by 453
Targeted Liposomal Drug Delivery to Monocytes and Macrophages
Kelly, C., Jefferies, C., & Cryan, S.-A. (2011) · Journal of Drug Delivery · doi:10.1155/2011/727241 · Cited by 425
Phillips, R. L., Miranda, O. R., You, C., Rotello, V. M., & Bunz, U. H. F. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703369 · Cited by 402
Swartz, M. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031807 · Cited by 396
Lipase-Sensitive Polymeric Triple-Layered Nanogel for “On-Demand” Drug Delivery
Xiong, M.-H., Bao, Y., Yang, X.-Z., Wang, Y.-C., Sun, B., & Wang, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211279u · Cited by 361
Tan, M. L., Choong, P. F. M., & Dass, C. R. (2010) · Peptides · doi:10.1016/j.peptides.2009.10.002 · Cited by 350
Nanoparticle-detained toxins for safe and effective vaccination
Hu, C.-M. J., Fang, R. H., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.254 · Cited by 342
Self-citationA magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria
Chung, H. J., Castro, C. M., Im, H., Lee, H., & Weissleder, R. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.70 · Cited by 339
High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes
Edgar, R., McKinstry, M., Hwang, J., Oppenheim, A. B., Fekete, R. A., Giulian, G., Merril, C., Nagashima, K., & Adhya, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601211103 · Cited by 338
Kell, A. J., Stewart, G., Ryan, S., Peytavi, R., Boissinot, M., Huletsky, A., Bergeron, M. G., & Simard, B. (2008) · ACS Nano · doi:10.1021/nn700183g · Cited by 320
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
Azzopardi, E. A., Ferguson, E. L., & Thomas, D. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks379 · Cited by 312
Hu, Y., Litwin, T., Nagaraja, A. R., Kwong, B., Katz, J., Watson, N., & Irvine, D. J. (2007) · Nano Letters · doi:10.1021/nl071542i · Cited by 305
Nanobioimaging and sensing of infectious diseases
Tallury, P., Malhotra, A., Byrne, L. M., & Santra, S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.014 · Cited by 301
Bacteria‐Responsive Multifunctional Nanogel for Targeted Antibiotic Delivery
Xiong, M., Li, Y., Bao, Y., Yang, X., Hu, B., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202847 · Cited by 299
Pornpattananangkul, D., Zhang, L., Olson, S., Aryal, S., Obonyo, M., Vecchio, K., Huang, C.-M., & Zhang, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111110e · Cited by 293
Self-citationPRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Biomedical applications of distally controlled magnetic nanoparticles
Corchero, J. L., & Villaverde, A. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.04.003 · Cited by 281
How to Stabilize Phospholipid Liposomes (Using Nanoparticles)
Zhang, L., & Granick, S. (2006) · Nano Letters · doi:10.1021/nl052455y · Cited by 278
Self-citationSambhy, V., Peterson, B. R., & Sen, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200702287 · Cited by 271
Schlosser, E., Mueller, M., Fischer, S., Basta, S., Busch, D. H., Gander, B., & Groettrup, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.030 · Cited by 262
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
Vyas, S. P., Kannan, M. E., Jain, S., Mishra, V, & Singh, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262
pH-dependent Perforation of Macrophage Phagosomes by Listeriolysin O from Listeria monocytogenes
Beauregard, K. E., Lee, K.-D., Collier, R. J., & Swanson, J. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1159 · Cited by 260
The potential of desferrioxamine-gallium as an anti- Pseudomonas therapeutic agent
Banin, E., Lozinski, A., Brady, K. M., Berenshtein, E., Butterfield, P. W., Moshe, M., Chevion, M., Greenberg, E. P., & Banin, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808608105 · Cited by 258
Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates
Zhang, L., Radovic‐Moreno, A. F., Alexis, F., Gu, F. X., Basto, P. A., Bagalkot, V., Jon, S., Langer, R. S., & Farokhzad, O. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200700121 · Cited by 257
Self-citationHydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery
Gao, W., Vecchio, D., Li, J., Zhu, J., Zhang, Q., Fu, V., Li, J., Thamphiwatana, S., Lu, D., & Zhang, L. (2014) · ACS Nano · doi:10.1021/nn500110a · Cited by 249
Self-citationJewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Liposome-like nanostructures for drug delivery
Gao, W., Hu, C.-M. J., Fang, R. H., & Zhang, L. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21238f · Cited by 244
Self-citationTherapeutic potential of nanoparticulate systems for macrophage targeting
Chellat, F., Merhi, Y., Moreau, A., & Yahia, L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.044 · Cited by 237
Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability
DiStasi, M. R., & Ley, K. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.012 · Cited by 237
Slepushkin, V. A., Simões, S., Dazin, P., Newman, M. S., Guo, L. S., de Lima, M. C. P., & Düzgüneş, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2382 · Cited by 235
Ahmad, Z., Pandey, R., Sharma, S., & Khuller, G. K. (2006) · PubMed · Cited by 231
Detection of Single Bacterial Pathogens with Semiconductor Quantum Dots
Hahn, M. A., Tabb, J. S., & Krauss, T. D. (2005) · Analytical Chemistry · doi:10.1021/ac050641i · Cited by 229
Discovering new antimicrobial agents
Moellering, R. C. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.018 · Cited by 227
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
Briones, E., Isabel Colino, C., & Lanao, J. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.027 · Cited by 224
Engineering Approaches to Immunotherapy
Swartz, M. A., Hirosue, S., & Hubbell, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003763 · Cited by 224
Bacterial Subversion of Host Innate Immune Pathways
Baxt, L. A., Garza-Mayers, A. C., & Goldberg, M. B. (2013) · Science · doi:10.1126/science.1235771 · Cited by 205
Villa, C. H., Dao, T., Ahearn, I., Fehrenbacher, N., Casey, E., Rey, D. A., Korontsvit, T., Zakhaleva, V., Batt, C. A., Philips, M. R., et al. (2011) · ACS Nano · doi:10.1021/nn200182x · Cited by 205
Managing Antibiotic Resistance
Wenzel, R. P., & Edmond, M. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432610 · Cited by 204
Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy
Aryal, S., Hu, C.-M. J., & Zhang, L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200243k · Cited by 198
Self-citationQi, G., Li, L., Yu, F., & Wang, H. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am403940d · Cited by 192
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
Nembrini, C., Stano, A., Dane, K. Y., Ballester, M., van der Vlies, A. J., Marsland, B. J., Swartz, M. A., & Hubbell, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104264108 · Cited by 187
Zhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I. M., Klinman, D. M., & Berzofsky, J. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39293 · Cited by 186
Zhu, Q., Talton, J., Zhang, G., Cunningham, T., Wang, Z., Waters, R. C., Kirk, J., Eppler, B., Klinman, D. M., Sui, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2866 · Cited by 185
Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture
Chu, C.-J., Dijkstra, J., Lai, M.-Z., Hong, K., & Szoka, F. C. (1990) · Pharmaceutical Research · doi:10.1023/a:1015908831507 · Cited by 184
Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery
Aryal, S., Hu, C. J., & Zhang, L. (2010) · Small · doi:10.1002/smll.201000631 · Cited by 183
Self-citationLin, Y.-H., Chang, C.-H., Wu, Y.-S., Hsu, Y.-M., Chiou, S.-F., & Chen, Y.-J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.036 · Cited by 173
Stimuli-Responsive Liposome Fusion Mediated by Gold Nanoparticles
Pornpattananangkul, D., Olson, S., Aryal, S., Sartor, M., Huang, C.-M., Vecchio, K., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9018587 · Cited by 173
Self-citationRose, R. D., Zelikin, A. N., Johnston, A. P. R., Sexton, A. L., Chong, S., Cortez‐Jugo, C., Mulholland, W. J., Caruso, F., & Kent, S. J. (2008) · Advanced Materials · doi:10.1002/adma.200801826 · Cited by 154
On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes
Simões, S., Slepushkin, V., Düzgüneş, N., & de Lima, M. C. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00389-3 · Cited by 148
Choi, S. K., Myc, A., Silpe, J. E., Sumit, M., Wong, P. T., McCarthy, K. A., Desai, A. M., Thomas, T. P., Kotlyar, A., Holl, M. M. B., et al. (2012) · ACS Nano · doi:10.1021/nn3038995 · Cited by 148
Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity
Heit, A., Schmitz, F., Haas, T. L., Busch, D. H., & Wagner, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200737169 · Cited by 147
Novel vaccine development strategies for inducing mucosal immunity
Fukuyama, Y., Tokuhara, D., Kataoka, K., Gilbert, R. S., McGhee, Yuki, Y., Kiyono, H., & Fujihashi, K. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.196 · Cited by 146
Timko, B. P., Whitehead, K. A., Gao, W., Kohane, D. S., Farokhzad, O. C., Anderson, D. G., & Langer, R. (2011) · Annual Review of Materials Research · doi:10.1146/annurev-matsci-062910-100359 · Cited by 146
Self-citationTargeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles
Toti, U. S., Guru, B. R., Hali, M., McPharlin, C. M., Wykes, S. M., Panyam, J., & Whittum-Hudson, J. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.038 · Cited by 143
Halwani, M., Yebio, B., Suntres, Z. E., Alipour, M., Azghani, A. O., & Omri, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn422 · Cited by 140
Vaccines and antibiotic resistance
Mishra, R. P. N., Oviedo‐Orta, E., Prachi, P., Rappuoli, R., & Bagnoli, F. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.08.002 · Cited by 136
Nanoparticle-Stabilized Liposomes for pH-Responsive Gastric Drug Delivery
Thamphiwatana, S., Fu, V., Zhu, J., Lu, D., Gao, W., & Zhang, L. (2013) · Langmuir · doi:10.1021/la402695c · Cited by 130
Self-citationDeol, P., Khuller, G. K., & Joshi, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1211 · Cited by 128
Abdelhamid, H. N., & Wu, H. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21020k · Cited by 122
Lutwyche, P., Cordeiro, C., Wiseman, D. J., St-Louis, M., Uh, M., Hope, M. J., Webb, M. S., & Finlay, B. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2511 · Cited by 121
Taylor, S. L., Wahl‐Jensen, V., Copeland, A. M., Jahrling, P. B., & Schmaljohn, C. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003470 · Cited by 121
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004) · Current Drug Delivery · doi:10.2174/1567201043334597 · Cited by 118
Endothelial activation, dysfunction and permeability during severe infections
Lee, W. L., & Liles, W. C. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328345a3d1 · Cited by 117
Dark, P. M., Dean, P., & Warhurst, G. (2009) · Critical Care · doi:10.1186/cc7886 · Cited by 111
Umamaheshwari, R. B., & Jain, N. K. (2003) · Journal of drug targeting · doi:10.1080/10611860310001647771 · Cited by 110
Lee, K., Oh, Y., Portnoy, D. A., & Swanson, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7249 · Cited by 107
Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model
Pandey, R. B. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl128 · Cited by 107
Vaccines and the Future of Human Immunology
Germain, R. N. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.014 · Cited by 106
Chen, J., Zhang, C., Liu, Q., Shao, X., Feng, C., Shen, Y., Zhang, Q., & Jiang, X. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.622396 · Cited by 103
Drug delivery systems for potential treatment of intracellular bacterial infections
Imbuluzqueta, E., Gamazo, C., Ariza, J., & Blanco‐Prieto, M. J. (2009) · Frontiers in bioscience · doi:10.2741/3627 · Cited by 102
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Boerman, O. C., Storm, G., Oyen, W. J. G., van Bloois, L., van der Meer, J. W., Claessens, R. A. M. J., Crommelin, D. J. A., & Corstens, F. H. M. (1995) · PubMed · Cited by 102
Labana, S., Pandey, R., Sharma, S., & Khuller, G. K. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00175-9 · Cited by 101
Precision Intracellular Delivery Based on Optofluidic Polymersome Rupture
Vasdekis, A. E., Scott, E. A., O’Neil, C. P., Psaltis, D., & Hubbell, J. A. (2012) · ACS Nano · doi:10.1021/nn302122h · Cited by 94
Aminoglycoside therapy in infectious diseases
Poulikakos, P., & Falagas, M. E. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.806486 · Cited by 90
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Oyen, W. J. G., Boerman, O. C., Storm, G., van Bloois, L., Koenders, E. B., Claessens, R. A. M. J., Perenboom, R. M., Crommelin, D. J. A., van der Meer, J. W. M., & Corstens, F. H. M. (1996) · PubMed · Cited by 88
Choi, K.-H., Lee, H.-J., Park, B. J., Wang, K., Shin, E. P., Park, J., Kim, Y. K., Oh, M., & Kim, Y.-R. (2012) · Chemical Communications · doi:10.1039/c2cc17766h · Cited by 87
Majumdar, S., Flasher, D., Friend, D. S., NASSOS, P. S., Yajko, D. M., HADLEY, W. K., & Düzgüneş, N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2808 · Cited by 86
Gürsoy, A., Kut, E., & Özkırımlı, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.033 · Cited by 83
Cordeiro, C., Wiseman, D. J., Lutwyche, P., Uh, M., Evans, J. C., Finlay, B. B., & Webb, M. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.533-539.2000 · Cited by 82
Alipour, M., Suntres, Z. E., Lafrenie, R. M., & Omri, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq036 · Cited by 78
Huang, P., Tay, L., Tanha, J., Ryan, S., & Chau, L. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901397 · Cited by 76
Tay, L., Huang, P., Tanha, J., Ryan, S., Wu, X., Hulse, J. E., & Chau, L. (2011) · Chemical Communications · doi:10.1039/c1cc16325f · Cited by 76
Orr, M. T., Beebe, E. A., Hudson, T. E., Moon, J. J., Fox, C. B., Reed, S. G., & Coler, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083884 · Cited by 74
Kaim, A. H., Wischer, T. K., O’Reilly, T., Jundt, G., Froehlich, J. M., von Schulthess, G. K., & ALLEGRINI, P. R. (2002) · Radiology · doi:10.1148/radiol.2253011485 · Cited by 73
Combination of adjuvants: the future of vaccine design
Mount, A. M., Koernig, S., Silva, A., Drane, D. P., Maraskovsky, E., & Morelli, A. B. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.811185 · Cited by 70
Li, Y., Su, T., Zhang, Y., Huang, X., Li, J., & Li, C. (2014) · Drug Delivery · doi:10.3109/10717544.2014.880756 · Cited by 67
Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomonas
Dillen, K., Bridts, C. H., der Veken, P. V., Cos, P., Vandervoort, J., Augustyns, K., Stevens, W. J., & Ludwig, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.041 · Cited by 67
Ramteke, S., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860701733278 · Cited by 67
Bacteria tracking by in vivomagnetic resonance imaging
Hoerr, V., Tuchscherr, L. P. N., Hüve, J., Nippe, N., Loser, K., Glyvuk, N., Tsytsyura, Y., Holtkamp, M., Sunderkötter, C. H., Kärst, U., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-63 · Cited by 66
Jain, P., Jain, S., Jain, S., Prasad, K. N., Jain, S. K., Jain, S., & Vyas, S. P. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8002539 · Cited by 65
Quantum dot probes for bacteria distinguish Escherichia coli mutants and permit in vivo imaging
Leevy, W. M., Lambert, T. N., Johnson, J. R., Morris, J. D., & Smith, B. D. (2008) · Chemical Communications · doi:10.1039/b803590c · Cited by 65
Treatment of experimental osteomyelitis by liposomal antibiotics
Kadry, A. A., Al‐Suwayeh, S. A., Abd‐Allah, A. R. A., & Bayomi, M. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh465 · Cited by 65
A microdevice for rapid optical detection of magnetically captured rare blood pathogens
Cooper, R. M., Leslie, D. C., Domanský, K., Jain, A., Yung, C. W., Cho, M., Workman, S., Super, M., & Ingber, D. E. (2013) · Lab on a Chip · doi:10.1039/c3lc50935d · Cited by 64
Ramteke, S., Ganesh, N., Bhattacharya, S., & Jain, N. K. (2009) · Journal of drug targeting · doi:10.1080/10611860902718649 · Cited by 64
Boerman, O. C., Oyen, W. J. G., van Bloois, L., Koenders, E. B., van der Meer, J. W., Corstens, F. H. M., & Storm, G. (1997) · PubMed · Cited by 63
Chronic Infectious Disease and the Future of Health Care Delivery
Farmer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1310472 · Cited by 59
TB or Not TB: That Is No Longer the Question
Modlin, R. L., & Bloom, B. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007402 · Cited by 59
Nanoparticle-Assisted Surface Immobilization of Phospholipid Liposomes
Zhang, L., Hong, L., Yu, Y., Bae, S. C., & Granick, S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062620r · Cited by 56
Self-citationMicroscopic localization of PEG-liposomes in a rat model of focal infection
Laverman, P., Dams, E. T. M., Storm, G., Hafmans, T. G., Croes, H. J., Oyen, W. J. G., Corstens, F. H. M., & Boerman, O. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00402-3 · Cited by 53
Alhariri, M., & Omri, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01634-12 · Cited by 53
Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin
Halwani, M., Blomme, S., Suntres, Z. E., Alipour, M., Azghani, A. O., Kumar, A., & Omri, A. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.008 · Cited by 44
Triple therapy-based targeted nanoparticles for the treatment ofHelicobacter pylori
Ramteke, S., Ganesh, N., Bhattacharya, S., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860802295839 · Cited by 42
Yue, H., Wei, W., Fan, B., Yue, Z., Wang, L., Ma, G., & Su, Z. G. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.09.008 · Cited by 39
In Vivo Synergistic Interaction of Liposome-Coencapsulated Gentamicin and Ceftazidime
Schiffelers, R. M., Storm, G., ten Kate, M. T., Stearne, L. E. T., den Hollander, J. G., Verbrugh, H. A., & Bakker‐Woudenberg, I. A. J. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29390-3 · Cited by 37
Ponnappa, B. C., Dey, I., Tu, G., Zhou, F., Aini, M., Cao, Q.-N., & Israel, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29642-7 · Cited by 36
Phagocyte Transport as Mechanism for Enhanced Therapeutic Activity of Liposomal Amphotericin B
Mehta, R. T., McQueen, T. J., Keyhani, A., & Lopez‐Berestein, G. (2009) · Chemotherapy · doi:10.1159/000239202 · Cited by 34
Ponnappa, B. C., Dey, I., Tu, G., Zhou, F., Aini, M., Cao, Q.-N., & Israel, Y. (2001) · PubMed · Cited by 33
Tschaikowsky, K. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90032-9 · Cited by 22
Reorienting our view of particle-based adjuvants for subunit vaccines
Little, S. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120993109 · Cited by 18
Cited by
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Shaikh, S., Nazam, N., Rizvi, S. M. D., Ahmad, K., Baig, M. H., Lee, E. J., & Choi, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102468 · Cited by 507
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Biomedical applications of nanotechnology
Ramos, A. P., Cruz, M. A. E., Tovani, C. B., & Ciancaglini, P. (2017) · Biophysical Reviews · doi:10.1007/s12551-016-0246-2 · Cited by 413
Metadata
- Authors
- Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2014-07-15
- Volume
- 6
- Issue
- 6
- Pages
- 532-547
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W1698551943
- Cited by
- 347
- References
- 157
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.